$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| IMFINZI RECOMMENDED FOR EU APPROVAL FOR LS-SCLC | 03 Feb 2025 |
| TOTAL VOTING RIGHTS | 03 Feb 2025 |
| ENHERTU APPROVED IN US FOR BREAST CANCER POST ET | 28 Jan 2025 |
| SCHEDULE 13D/A | 24 Jan 2025 |
| DATO-DXD APPROVED IN US FOR HR+ BREAST CANCER | 21 Jan 2025 |
| F-6 | 21 Jan 2025 |
| CALQUENCE COMBINATION APPROVED IN US FOR 1L MCL | 17 Jan 2025 |
| TOTAL VOTING RIGHTS | 02 Jan 2025 |
| DATO-DXD NSQ NSCLC APPLICATION WITHDRAWN IN EU | 26 Dec 2024 |
| TAGRISSO APPROVED IN EU BASED ON LAURA TRIAL | 23 Dec 2024 |
| DIRECTORATE CHANGE | 16 Dec 2024 |
| IMFINZI APPROVED IN US FOR LIMITED-STAGE SCLC | 05 Dec 2024 |
| ASTRAZENECA APPOINTS ISKRA REIC EVP INTERNATIONAL | 04 Dec 2024 |
| BLOCK LISTING INTERIM REVIEW | 02 Dec 2024 |
| TOTAL VOTING RIGHTS | 02 Dec 2024 |
| TRUQAP IMPROVED RPFS IN ADVANCED PROSTATE CANCER | 25 Nov 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 20 Nov 2024 |
| TAGRISSO RECOMMENDED FOR EU APPROVAL - LAURA | 18 Nov 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 15 Nov 2024 |
| DIRECTOR/PDMR SHAREHOLDING | 15 Nov 2024 |
